{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:05:01Z","timestamp":1791612301859,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabotropic glutamate receptor 5 (mGluR5) is involved in regulating integrative brain function and synaptic transmission. Aberrant mGluR5 signaling and relevant synaptic failure play a key role in the initial pathophysiological mechanism of Alzheimer\u2019s disease (AD). The study aims to investigate the association between mGluR5 availability and AD\u2019s biomarkers and cognitive function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We examined 35 individuals with mGluR5 tracer [\n                      <jats:sup>18<\/jats:sup>\n                      F]PSS232 to assess mGluR5 availability, and with [\n                      <jats:sup>18<\/jats:sup>\n                      F]Florbetapir PET to assess global amyloid deposition, and [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG PET to assess glucose metabolism. The plasma neurofilament light (NfL) and p-tau181 levels in a subset of individuals were measured (\n                      <jats:italic>n<\/jats:italic>\n                      = 27). The difference in mGluR5 availability between the AD and normal control (NC) groups was explored. The associations of mGluR5 availability with amyloid deposition, glucose metabolism, gray matter volume (GMV), neuropsychological assessment scores, and plasma biomarkers were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mGluR5 availability was significantly reduced in AD patients\u2019 hippocampus and parahippocampal gyrus compared to NCs. Global amyloid deposition was positively associated with mGluR5 availability in the AD group and reversely associated in the NC group. The mGluR5 availability was positively correlated with regional glucose metabolism in the overall and stratified analyses. The availability of mGluR5 in the hippocampus and parahippocampal gyrus demonstrated a strong relationship with the GMV of the medial temporal lobe, plasma p-tau181 or NfL levels, and global cognitive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:sup>18<\/jats:sup>\n                      F]PSS232 PET can quantify the changes of mGluR5 availability in the progression of AD. mGluR5 availability correlated not only with neuropathological biomarkers of AD but also with neurodegenerative biomarkers and cognitive performance. mGluR5 may be a novel neurodegenerative biomarker, and whether mGluR5 could be a potential therapeutic target for AD needs to be further studied.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01385-z","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T01:01:59Z","timestamp":1705021319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer\u2019s disease: A [18F]PSS232 PET\/MRI study"],"prefix":"10.1186","volume":"16","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Schibli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum RL, Ellis CE. Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med. 2003;348:1356\u201364.","journal-title":"N Engl J Med"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"Association As","year":"2019","unstructured":"As Association. 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2019;15:321\u201387.","journal-title":"Alzheimer's Dement"},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/BF02895923","volume":"1","author":"JR Ro\u00dfbach","year":"1910","unstructured":"Ro\u00dfbach JR. \u00dcber einen eigenartigen Zerst\u00f6rungsproze\u00df der Hirnrinde auf arteriosklerotischer Grundlage (\u00e9tat vermoulu Pierre Marie\u2019s). Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie. 1910;1:92\u2013104.","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie."},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","volume":"20","author":"H Awad","year":"2000","unstructured":"Awad H, Hubert GW, Smith Y, Levey AI, Conn PJ. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J Neurosci. 2000;20:7871\u20139.","journal-title":"J Neurosci"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","volume":"62","author":"KS Abd-Elrahman","year":"2022","unstructured":"Abd-Elrahman KS, Ferguson SSG. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer\u2019s Disease. Annu Rev Pharmacol Toxicol. 2022;62:235\u201354.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0028-3908(95)00085-K","volume":"34","author":"LP Daggett","year":"1995","unstructured":"Daggett LP, Sacaan AI, Akong M, Rao SP, Hess SD, Liaw C, et al. Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5. Neuropharmacology. 1995;34:871\u201386.","journal-title":"Neuropharmacology"},{"key":"1385_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-9-43","volume":"9","author":"KR Byrnes","year":"2012","unstructured":"Byrnes KR, Loane DJ, Stoica BA, Zhang J, Faden AI. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation. 2012;9:43.","journal-title":"J Neuroinflammation"},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","volume":"3","author":"KS Abd-Elrahman","year":"2020","unstructured":"Abd-Elrahman KS, Hamilton A, Albaker A, Ferguson SSG. mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent. ACS Pharmacol Transl Sci. 2020;3:334\u201344.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1385_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jnc.12615","volume":"129","author":"PA Abushik","year":"2014","unstructured":"Abushik PA, Niittykoski M, Giniatullina R, Shakirzyanova A, Bart G, Fayuk D, et al. The role of NMDA and mGluR5 receptors in calcium mobilization and neurotoxicity of homocysteine in trigeminal and cortical neurons and glial cells. J Neurochem. 2014;129:264\u201374.","journal-title":"J Neurochem"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neuron.2010.04.029","volume":"66","author":"M Renner","year":"2010","unstructured":"Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, et al. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron. 2010;66:739\u201354.","journal-title":"Neuron"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/brain\/awv356","volume":"139","author":"LT Haas","year":"2016","unstructured":"Haas LT, Salazar SV, Kostylev MA, Um JW, Kaufman AC, Strittmatter SM. Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer\u2019s disease. Brain. 2016;139:526\u201346.","journal-title":"Brain"},{"key":"1385_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-6606-7-40","volume":"7","author":"A Hamilton","year":"2014","unstructured":"Hamilton A, Esseltine JL, DeVries RA, Cregan SP, Ferguson SS. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer\u2019s disease. Mol Brain. 2014;7:40.","journal-title":"Mol Brain"},{"key":"1385_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-020-0582-0","volume":"12","author":"AP Mecca","year":"2020","unstructured":"Mecca AP, McDonald JW, Michalak HR, Godek TA, Harris JE, Pugh EA, et al. PET imaging of mGluR5 in Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12:15.","journal-title":"Alzheimers Res Ther"},{"key":"1385_CR15","doi-asserted-by":"publisher","first-page":"e01632","DOI":"10.1002\/brb3.1632","volume":"10","author":"V Treyer","year":"2020","unstructured":"Treyer V, Gietl AF, Suliman H, Gruber E, Meyer R, Buchmann A, et al. Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer\u2019s dementia. Brain Behav. 2020;10:e01632.","journal-title":"Brain Behav"},{"key":"1385_CR16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00259-017-3879-x","volume":"45","author":"G Warnock","year":"2018","unstructured":"Warnock G, Sommerauer M, Mu L, Pla Gonzalez G, Geistlich S, Treyer V, et al. A first-in-man PET study of [(18)F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5. Eur J Nucl Med Mol Imaging. 2018;45:1041\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"1385_CR18","doi-asserted-by":"crossref","unstructured":"Lundeen T, Seibyl J, Covington M, Eshghi N, Kuo P. Signs and Artifacts in Amyloid PET. Radiographics: a review publication of the Radiological Society of North America, Inc. 2018;38:2123-33.","DOI":"10.1148\/rg.2018180160"},{"key":"1385_CR19","doi-asserted-by":"publisher","first-page":"832700","DOI":"10.3389\/fnagi.2022.832700","volume":"14","author":"F Pan","year":"2022","unstructured":"Pan F, Huang Q, Wang Y, Wang Y, Guan Y, Xie F, et al. Non-linear character of plasma amyloid beta over the course of cognitive decline in alzheimer\u2019s continuum. Front Aging Neurosci. 2022;14:832700.","journal-title":"Front Aging Neurosci"},{"key":"1385_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1073\/pnas.1210984110","volume":"110","author":"F Akkus","year":"2013","unstructured":"Akkus F, Ametamey SM, Treyer V, Burger C, Johayem A, Umbricht D, et al. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography. Proc Natl Acad Sci U S A. 2013;110:737\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/WAD.0b013e3181999e92","volume":"23","author":"Q Guo","year":"2009","unstructured":"Guo Q, Zhao Q, Chen M, Ding D, Hong Z. A comparison study of mild cognitive impairment with 3 memory tests among Chinese individuals. Alzheimer Dis Assoc Disord. 2009;23:253\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12264-013-1301-7","volume":"29","author":"Q Zhao","year":"2013","unstructured":"Zhao Q, Guo Q, Hong Z. Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment. Neurosci Bull. 2013;29:75\u201382.","journal-title":"Neurosci Bull"},{"key":"1385_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.2174\/1567205012666150530202729","volume":"12","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Guo Q, Liang X, Chen M, Zhou Y, Ding D, et al. Auditory verbal learning test is superior to rey-osterrieth complex figure memory for predicting mild cognitive impairment to alzheimer\u2019s disease. Curr Alzheimer Res. 2015;12:520\u20136.","journal-title":"Curr Alzheimer Res"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/0271678X231153730","volume":"43","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang J, Xu X, You Z, Huang Q, Huang Y, et al. In vivo synaptic density loss correlates with impaired functional and related structural connectivity in Alzheimer\u2019s disease. J Cerebral Blood Flow Metab. 2023;43:977\u201388.","journal-title":"J Cerebral Blood Flow Metab"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-221251","volume":"93","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Wang J, Wang Y, Liu X, He K, Guo Q, et al. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer\u2019s Disease Biomarkers in Subjective Cognitive Decline Population. J Alzheimers Dis. 2023;93:585\u201394.","journal-title":"J Alzheimers Dis"},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00406-019-01083-0","volume":"270","author":"Q Huang","year":"2020","unstructured":"Huang Q, Ren S, Jiang D, Guan Y, Xie F, Sun D, et al. Changes in brain glucose metabolism and connectivity in somatoform disorders: an (18)F-FDG PET study. Eur Arch Psychiatry Clin Neurosci. 2020;270:881\u201391.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1385_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuroscience.2019.07.048","volume":"417","author":"J Su","year":"2019","unstructured":"Su J, Huang Q, Ren S, Xie F, Zhai Y, Guan Y, et al. Altered Brain Glucose Metabolism Assessed by (18)F-FDG PET Imaging Is Associated with the Cognitive Impairment of CADASIL. Neuroscience. 2019;417:35\u201344.","journal-title":"Neuroscience"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-140669","volume":"49","author":"M Sattlecker","year":"2016","unstructured":"Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, K\u0142oszewska I, et al. Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer\u2019s Disease. J Alzheimers Dis. 2016;49:1105\u201314.","journal-title":"J Alzheimers Dis"},{"key":"1385_CR29","doi-asserted-by":"crossref","unstructured":"Pan. F-F, Huang. Q, Wang. Y, Wang. Y-F, Guan. Y-H, Xie2. F, et al. Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer\u2019s Continuum. Front Aging Neurosci. 2022;14:832700.","DOI":"10.3389\/fnagi.2022.832700"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","volume":"147","author":"G Gonzalez-Escamilla","year":"2017","unstructured":"Gonzalez-Escamilla G, Lange C, Teipel S, Buchert R, Grothe MJ. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET. Neuroimage. 2017;147:669\u201377.","journal-title":"Neuroimage"},{"key":"1385_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273\u201389.","journal-title":"Neuroimage"},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2012.09.012","volume":"34","author":"TL Sudduth","year":"2013","unstructured":"Sudduth TL, Schmitt FA, Nelson PT, Wilcock DM. Neuroinflammatory phenotype in early Alzheimer\u2019s disease. Neurobiol Aging. 2013;34:1051\u20139.","journal-title":"Neurobiol Aging"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3233\/JAD-201146","volume":"78","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Das B, Yao AY, Yan R. Metabotropic glutamate receptors in alzheimer\u2019s disease synaptic dysfunction: therapeutic opportunities and hope for the future. J Alzheimer\u2019s Dis. 2020;78:1345\u201361.","journal-title":"J Alzheimer's Dis"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2008.12.082","volume":"1260","author":"CS Casley","year":"2009","unstructured":"Casley CS, Lakics V, Lee HG, Broad LM, Day TA, Cluett T, et al. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-\u03b2 peptide. Brain Res. 2009;1260:65\u201375.","journal-title":"Brain Res"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neurobiolaging.2019.08.006","volume":"84","author":"M Lee","year":"2019","unstructured":"Lee M, Lee HJ, Jeong YJ, Oh SJ, Kang KJ, Han SJ, et al. Age dependency of mGluR5 availability in 5xFAD mice measured by PET. Neurobiol Aging. 2019;84:208\u201316.","journal-title":"Neurobiol Aging"},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke J, Thota R, Villemagne V, Dor\u00e9 V, et al. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimer\u2019s Dementia. 2023;19:1117\u201334.","journal-title":"Alzheimer's Dementia"},{"key":"1385_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"E Thijssen","year":"2020","unstructured":"Thijssen E, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration. Nat Med. 2020;26:387\u201397.","journal-title":"Nat Med"},{"key":"1385_CR38","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1038\/s41467-021-24319-x","volume":"12","author":"A Lleo","year":"2021","unstructured":"Lleo A, Zetterberg H, Pegueroles J, Karikari TK, Carmona-Iragui M, Ashton NJ, et al. Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer\u2019s disease in adults with Down syndrome. Nat Commun. 2021;12:4304.","journal-title":"Nat Commun"},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med. 2020;26:379\u201386.","journal-title":"Nat Med"},{"key":"1385_CR40","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"T Karikari","year":"2020","unstructured":"Karikari T, Pascoal T, Ashton N, Janelidze S, Benedet A, Rodriguez J, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422\u201333.","journal-title":"Lancet Neurol"},{"key":"1385_CR41","doi-asserted-by":"publisher","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","volume":"32","author":"M Larson","year":"2012","unstructured":"Larson M, Sherman M, Amar F, Nuvolone M, Schneider J, Bennett D, et al. The complex PrP(c)-Fyn couples human oligomeric A\u03b2 with pathological tau changes in Alzheimer\u2019s disease. J Neurosci. 2012;32:16857\u201371a.","journal-title":"J Neurosci"},{"key":"1385_CR42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2017;74:557\u201366.","journal-title":"JAMA Neurol"},{"key":"1385_CR43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 2019;76:791\u20139.","journal-title":"JAMA Neurol"},{"key":"1385_CR44","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.celrep.2016.04.077","volume":"15","author":"A Hamilton","year":"2016","unstructured":"Hamilton A, Vasefi M, Vander Tuin C, McQuaid RJ, Anisman H, Ferguson SS. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Cell Rep. 2016;15:1859\u201365.","journal-title":"Cell Rep"},{"key":"1385_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","volume":"13","author":"RS O'Dell","year":"2021","unstructured":"O\u2019Dell RS, Mecca AP, Chen MK, Naganawa M, Toyonaga T, Lu Y, et al. Association of A\u03b2 deposition and regional synaptic density in early Alzheimer\u2019s disease: a PET imaging study with [(11)C]UCB-J. Alzheimers Res Ther. 2021;13:11.","journal-title":"Alzheimers Res Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01385-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01385-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01385-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T01:04:59Z","timestamp":1705021499000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01385-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01385-z","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study protocols were approved by the Institutional Review Boards of Huashan Hospital and Shanghai Jiao Tong University Affiliated Sixth People\u2019s Hospital. Written informed consent was provided by participants or their family members.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}